NCT04391933

Brief Summary

The main purpose of this study is to investigate whether magnetic ressonance imaging (MRI) can be used in treatment planning with assessment of diagnostic accuracy. With the inclusion of 150 patients the study will investigate whether MRI is useful and better than CT scanning in patients with colon tumors. And also if MRI is useful after neoadjuvant treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 18, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

March 10, 2021

Status Verified

May 1, 2020

Enrollment Period

2.3 years

First QC Date

May 13, 2020

Last Update Submit

March 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Is MRI usefull in colon cancer patients

    Investigate the degree of accuracy in tumor stage compared to the histopathological surgical composition.

    2 years

Study Arms (1)

MRI colon cancer

OTHER

MRI scan of patients with colon cancer

Diagnostic Test: MRI 3 tesla

Interventions

MRI 3 teslaDIAGNOSTIC_TEST

MRI of colon cancer. Sensitivity, specificity, positivity predictive values and negative predictive values are calculated form the histopathological surgical specimen. This will be the endpoint for both CT and MRI.

MRI colon cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with colon cancer
  • years old or older
  • Written and verbally informed consent

You may not qualify if:

  • Pacemakers, implanted medical pumps, and nerve stimulators
  • Cochlea implants and cerebral aneurism clips will in some cases be absolute contraindications to MRI examinations.
  • Previous treatment with radiation and or chemotherapy
  • Serious disease that contraindicates surgical treatment, including severe heart disease
  • Any type of cancer other than of the colon (excluding skin cancer, cancer in situ, endometrial cancer, malignant melanoma)
  • Any other condition or disease that from the investigator's point of view makes it inappropriate for the patient to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vejle Hospital

Vejle, DK-7100, Denmark

Location

Related Links

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Søren R Rafaelsen, MD, DMSc

    Vejle Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Sensitivity, specificity, positivity predictive values and negative predictive values are calculated form the histopathological surgical specimen. This will be the endpoint for both CT and MRI.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2020

First Posted

May 18, 2020

Study Start

September 1, 2018

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

March 10, 2021

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Informed Consent Form (CPR)Access

Locations